Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001504167-14-000037
Filing Date
2014-01-17
Accepted
2014-01-17 16:12:48
Documents
38
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q/A 256057
2 EX31_1 ex31_1.htm EX-31.1 9237
3 EX31_2 ex31_2.htm EX-31.2 9226
4 EX32_1 ex32_1.htm EX-32.1 4156
6 GRAPHIC image_001.gif GRAPHIC 2768
13 filename13.htm CORRESP 71176
  Complete submission text file 0001504167-14-000037.txt   1315438

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rcha-20130930.xml EX-101.INS 59558
8 XBRL SCHEMA FILE rcha-20130930.xsd EX-101.SCH 15235
9 XBRL CALCULATION FILE rcha-20130930_cal.xml EX-101.CAL 13480
10 XBRL DEFINITION FILE rcha-20130930_def.xml EX-101.DEF 42077
11 XBRL LABEL FILE rcha-20130930_lab.xml EX-101.LAB 81522
12 XBRL PRESENTATION FILE rcha-20130930_pre.xml EX-101.PRE 82836
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (323) 424-3169
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

EIN.: 463259117 | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 000-54767 | Film No.: 14535280
SIC: 3430 Heating Equip, Except Elec & Warm Air; & Plumbing Fixtures